| AED billions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.1 | 3.1 | 4.1 | 4.6 | 4.9 | 4.8 | 5.0 | +3.7% | |
| Cost of revenue | 1.6 | 2.3 | 3.1 | 3.3 | 3.5 | 3.5 | 3.5 | −0.9% | |
| Gross profit | 0.5 | 0.7 | 1.0 | 1.3 | 1.4 | 1.3 | 1.5 | +16.0% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +5.9% | |
| Operating expenses | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | 1.1 | 1.2 | +12.5% | |
| Operating income | (0.1) | 0.1 | 0.2 | 0.4 | 0.4 | 0.2 | 0.3 | +33.7% | |
| Interest expense | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | −1.1% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | +48.2% | |
| Pre-tax income | 0.0 | 0.3 | 0.3 | 0.4 | 0.4 | 0.1 | 0.2 | +62.7% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | +26.6% | |
| Net income | 0.0 | 0.2 | 0.2 | 0.3 | 0.3 | 0.1 | 0.2 | +83.3% | |
| EPS, basic (per share) | 0.05 | 0.27 | 0.30 | 0.31 | 0.36 | 0.10 | 0.19 | +83.3% | |
| EPS, diluted (per share) | 0.05 | 0.27 | 0.30 | 0.31 | 0.36 | 0.10 | 0.19 | +83.3% | |
| EBITDA | 0.1 | 0.3 | 0.4 | 0.7 | 0.6 | 0.4 | 0.5 | +20.5% | |
| Depreciation & amortization | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | +5.1% | |
| Weighted average shares (shares) | 629,999,964 | 792,712,155 | 831,155,803 | 831,155,803 | 818,869,000 | 831,156,000 | — | — | |
| Weighted average diluted shares (shares) | 629,999,964 | 792,712,155 | 831,155,803 | 831,155,803 | 818,869,000 | 831,156,000 | — | — | |
| Gross margin | 23.3% | 24.3% | 23.5% | 28.1% | 28.2% | 27.3% | 30.5% | +3.2 pts | |
| Operating margin | −3.7% | 2.8% | 4.8% | 9.4% | 8.2% | 4.5% | 5.8% | +1.3 pts | |
| Net margin | 1.7% | 7.0% | 6.1% | 5.7% | 5.9% | 1.8% | 3.1% | +1.4 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
